fat loss
Quality Rating
Buy O-304 (ATX-304) 100mg x60 Capsules
Pan-AMPK activator with GLP-1 synergy — NASH, diabetes, and fat loss in one compound
Pan-AMPK activationEndogenous GLP-1 stimulationNASH regression
Who This Is For
Users with metabolic syndrome, insulin resistance, or NASH who want a single oral compound addressing multiple aspects of metabolic dysfunction.
Overview & Benefits
O-304 (now ATX-304) activates all AMPK complexes — a broader activation than AICAR — producing insulin sensitization, fat oxidation, hepatic fat reduction, and gut hormone secretion including GLP-1 and PYY. Phase 2 data in type 2 diabetes showed significant glucose lowering, weight loss, and NASH biomarker improvement.
What distinguishes O-304 is the gut hormone effect: by stimulating endogenous GLP-1 release, it adds appetite suppression on top of the metabolic AMPK effects. This makes it a genuinely multi-mechanism compound for metabolic syndrome — addressing insulin resistance, hepatic fat, body weight, and appetite through different but synergistic pathways.
Key Benefits
- Pan-AMPK activation — broader than AICAR, affecting all AMPK complexes
- Stimulates endogenous GLP-1 and PYY release for appetite suppression
- NASH regression in Phase 2 — significant hepatic fat reduction
- Insulin sensitization and glucose lowering in diabetic subjects
- Multi-mechanism: metabolic + appetite via endogenous gut hormone stimulation
Protocols & Dosing
Daily Metabolic Protocol
Once or twice daily with meals100mg oral capsule
Take with food to minimize GI effects. Run 8–12 week cycles. Monitor fasting glucose and liver enzymes.
Buy O-304 (ATX-304) 100mg x60 Capsules
$119.99
Buy Now — $119.99Buy at PhiogenResearch-grade · COA verified · Phiogen
Categoryfat loss
Typeoral
Quality Rating★★★☆☆
VendorPhiogen
Also Needed
O-304 (ATX-304) 100mg x60 Capsules
$119.99